HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesca Daniel Selected Research

Oxaliplatin (Eloxatin)

9/2023Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesca Daniel Research Topics

Disease

8Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 01/2021
5Neoplasms (Cancer)
11/2023 - 01/2021
1Hypertension (High Blood Pressure)
02/2022
1Obesity
01/2022
1Microsatellite Instability
01/2021

Drug/Important Bio-Agent (IBA)

4Bevacizumab (Avastin)FDA Link
11/2023 - 01/2022
1encorafenibIBA
09/2023
1Cetuximab (Erbitux)FDA Link
09/2023
1Irinotecan (Camptosar)FDA LinkGeneric
09/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2023
1human ERBB2 proteinIBA
04/2022
1Biomarkers (Surrogate Marker)IBA
02/2022
1Circulating Tumor DNAIBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Panitumumab (Vectibix)FDA Link
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2021

Therapy/Procedure

4Therapeutics
11/2023 - 01/2021
3Drug Therapy (Chemotherapy)
11/2023 - 01/2022
1Palliative Care (Palliative Therapy)
01/2022